Insurance Coverage for Psychedelic Therapy
Bill of Health
MARCH 27, 2024
By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. This is typical—without a seal of approval from FDA, insurers are reluctant to pay for off-label treatments.
Let's personalize your content